Navigation Links
Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
Date:9/18/2007

NEW YORK, Sept. 18 /PRNewswire-FirstCall/ -- Siemens Corporation, a wholly owned subsidiary of Siemens AG (NYSE: SI), announced today that the statutory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, applicable to its cash tender offer for all of the issued and outstanding shares of common stock of Dade Behring Holdings, Inc. (Nasdaq: DADE) has been terminated.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

Siemens Corporation, through its wholly owned subsidiary Belfast Merger Co., commenced a tender offer on August 8, 2007 for all of the outstanding shares of common stock of Dade Behring for $77 per share, net to the seller in cash. On September 5, 2007, the tender offer was extended to 12:00 Midnight, New York City time, on Wednesday, September 26, 2007.

Siemens has submitted a draft of the required merger control filing with the European Commission and has since been in discussions with the authority. Siemens believes that it is possible that it might obtain competition law clearance, and therefore be able to close the transaction, during calendar 2007.

Following completion of the tender offer, any remaining shares of Dade Behring Holdings, Inc. will be acquired in a merger at the same price. The transaction is conditioned on, among other things, receipt of regulatory approvals and has a value of approximately $7 billion.

About Siemens

Siemens AG (NYSE: SI) (Berlin and Munich) is a global powerhouse in electrical engineering and electronics. The company has around 475,000 employees (incl. discontinued operations) working to develop and manufacture products, design and install complex systems and projects, and tailor a wide range of services for individual requirements. Siemens provides innovative technologies and comprehensive know-how to benefit customers in over 190 countries. Founded more than 160 years ago, the company focuses on the areas of Information and Communications, Automation and Control, Power, Transportation, Medical, and Lighting. In fiscal 2006 (ended September 30), Siemens had sales of euro 87.3 billion and net income of euro 3.033 billion, according to U.S. GAAP. Further information is available on the Internet at: http://www.siemens.com.

About Dade Behring

With 2006 revenue of more than US$1.7 billion, Dade Behring offers a wide range of products, systems and services designed to meet the day-to-day needs of clinical laboratories, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the Internet at http://www.dadebehring.com.

This announcement is for informational purposes only and does not constitute an offer to purchase nor a solicitation of an offer to sell any securities. The Tender Offer Statement on Schedule TO, the Offer to Purchase and related materials filed by Siemens with the Securities and Exchange Commission ("SEC") contain important information and should be read carefully before any decision is made with respect to the tender offer. These materials are available at no charge on the SEC's web site (http://www.sec.gov) and requests for additional copies of such materials may be directed to Georgeson Inc., the Information Agent for the tender offer. The Information Agent can be reached at 17 State Street, 10th Floor, New York, New York 10004. Banks and brokers can call (212) 440-9800 and all others can call toll free at (888) 605-7608.


'/>"/>
SOURCE Siemens Medical Solutions
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... Missouri (PRWEB) , ... August 18, 2017 , ... “Emotions ... Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To help change ... help children learn social and emotional skills, she created the Time-In Toolkit, which launched ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... tracking and monitoring solutions, announced today the launch of a redesigned corporate website, ... navigation and aesthetic, fully responsive design, and an enhanced search directory for businesses ...
(Date:8/18/2017)... ... , ... “Depressed: Super Heroes of the Bible”: a gripping and potent ... the relevance these tales may have on the reader’s life. “Depressed: Super Heroes of ... teacher, Jessica spends much of her time enjoying nature and her family in West ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Case #10-5411 Veterans ... Medical Center. “Case #10-5411 Veterans Administration” is the creation of published author, ... In June 1990, Carol Mulhem started work at the Coatesville VAMC as a ...
(Date:8/17/2017)... ... August 17, 2017 , ... Industry CEOs, ... 2017 for Anti-Infectives Rx. This off-the-record networking forum of the Boston Biotech Conference ... Medical School. , Industry leaders and decision makers will discuss issues facing the ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... Bio-Ess Laboratories, LLC Chief Science Officer, Dr. Adam Elhofy , will ... Cell-Ess® Universal Titer Boost at the 9 th annual ... 21-25.  The Bioprocessing Summit convenes more than 1,000 international bioprocess professionals to ... ... Cell-Ess is the ...
(Date:8/15/2017)... FLINT, Mich. , Aug. 15, 2017 ... antidote naloxone to Michigan residents. ... Diplomat,s Flint retail pharmacy, G-3320 ... Naloxone, approved by the Food and Drug Administration, is ... drugs—including extreme drowsiness, slowed breathing, and loss of consciousness. ...
(Date:8/15/2017)... , Aug. 15, 2017 AccuGenomics, Inc., ... , today announced that the company has provided ... University of North Carolina at Chapel Hill and to ... designed to characterize and quantify HIV reservoir and viral ... pharmacological intervention. The HIV Cure Center is a joint ...
Breaking Medicine Technology: